» Articles » PMID: 10960779

Mast Cells in the Cutaneous Lesions of Sarcoidosis: Their Subtypes and the Relationship to Systemic Manifestations

Overview
Journal J Dermatol Sci
Publisher Elsevier
Specialty Dermatology
Date 2000 Aug 29
PMID 10960779
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Possible involvement of mast cells in pulmonary sarcoidosis has been suggested, however whether mast cells are involved in cutaneous sarcoidosis remains unknown. We undertook a morphological study of mast cells in the lesional skin from 17 patients with cutaneous sarcoidosis using immunohistochemical methods. Mast cells were present in non-parenchymal fibrous areas, but not in granulomatous areas, in the biopsy specimens from the cutaneous lesions. However, there were no significant differences between the number of mast cells in the lesional skin and that in non-lesional skin from the patients. Mast cells containing substantial quantities of both tryptase and chymase (MC(TC) cells) were present in 41% of the patients, and cells containing tryptase but not chymase (MC(T) cells) were present in 59% of patients. All patients of the former group showed systemic manifestations of the disease concomitantly. Serum angiotensin I-converting enzyme levels were elevated in 71.4% of the former group, and in 30% of the latter group. This study for the first time demonstrated that mast cells were present in non-parenchymal fibrous areas of the cutaneous lesions of sarcoidosis, and the mast cell subtypes may be related to systemic manifestations.

Citing Articles

The analysis of tryptase in serum of sarcoidosis patients.

Bargagli E, Mazzi A, Mezzasalma F, Perrone A, Olivieri C, Prasse A Inflammation. 2009; 32(5):310-4.

PMID: 19582562 DOI: 10.1007/s10753-009-9137-z.


Key role of mast cells and their major secretory products in inflammatory bowel disease.

He S World J Gastroenterol. 2004; 10(3):309-18.

PMID: 14760748 PMC: 4724914. DOI: 10.3748/wjg.v10.i3.309.